清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Topical and oral steroids for otitis media with effusion (OME) in children

医学 中耳炎 小心等待 不利影响 儿科 生活质量(医疗保健) 随机对照试验 社会心理的 安慰剂 致盲 腺样体切除术 内科学 外科 精神科 扁桃体切除术 护理部 病理 替代医学 癌症 前列腺癌
作者
Caroline Mulvaney,Kevin Galbraith,Katie E Webster,Mridul Rana,Rachel Connolly,Ben Tudor‐Green,Tal Marom,Mat Daniel,Roderick P Venekamp,Anne GM Schilder,Samuel MacKeith
出处
期刊:The Cochrane library [Wiley]
卷期号:2023 (12) 被引量:7
标识
DOI:10.1002/14651858.cd015255.pub2
摘要

Background Otitis media with effusion (OME) is an accumulation of fluid in the middle ear cavity, common amongst young children. The fluid may cause hearing loss. Although most episodes of OME in children resolve spontaneously within a few months, when persistent it may lead to behavioural problems and a delay in expressive language skills. Management of OME includes watchful waiting, medical, surgical and other treatments, such as autoinflation. Oral or topical steroids are sometimes used to reduce inflammation in the middle ear. Objectives To assess the effects (benefits and harms) of topical and oral steroids for OME in children. Search methods We searched the Cochrane ENT Register, CENTRAL, Ovid MEDLINE, Ovid Embase, Web of Science, ClinicalTrials.gov, ICTRP and additional sources for published and unpublished studies on 20 January 2023. Selection criteria We included randomised controlled trials (RCTs) and quasi‐randomised trials in children aged 6 months to 12 years with unilateral or bilateral OME. We included studies that compared topical or oral steroids with either placebo or watchful waiting (no treatment). Data collection and analysis We used standard Cochrane methods. Our primary outcomes, determined by a multi‐stakeholder prioritisation exercise, were: 1) hearing, 2) OME‐specific quality of life and 3) systemic corticosteroid side effects. Secondary outcomes were: 1) presence/persistence of OME, 2) other adverse effects (including local nasal effects), 3) receptive language skills, 4) speech development, 5) cognitive development, 6) psychosocial outcomes, 7) listening skills, 8) generic health‐related quality of life, 9) parental stress, 10) vestibular function and 11) episodes of acute otitis media. We used GRADE to assess the certainty of evidence. Although we included all measures of hearing assessment, the proportion of children who returned to normal hearing was our preferred method to assess hearing, due to challenges in interpreting the results of mean hearing thresholds. Main results We included 26 studies in this review (2770 children). Most studies of oral steroids used prednisolone for 7 to 14 days. Studies of topical (nasal) steroids used various preparations (beclomethasone, fluticasone and mometasone) for between two weeks and three months. All studies had at least some concerns regarding risk of bias. Here we report our primary outcomes and main secondary outcome, at the longest reported follow‐up. Oral steroids compared to placebo Oral steroids probably result in little or no difference in the proportion of children with normal hearing after 12 months (69.7% of children with steroids, compared to 61.1% of children receiving placebo, risk ratio (RR) 1.14, 95% confidence interval (CI) 0.97 to 1.33; 1 study, 332 participants; moderate‐certainty evidence). There is probably little or no difference in OME‐related quality of life (mean difference (MD) in OM8‐30 score 0.07, 95% CI ‐0.2 to 0.34; 1 study, 304 participants; moderate‐certainty evidence). Oral steroids may reduce the number of children with persistent OME at 6 to 12 months, but the size of the effect was uncertain (absolute risk reduction ranging from 13.3% to 45%, number needed to treat (NNT) of between 3 and 8; low‐certainty evidence). The evidence was very uncertain regarding the risk of systemic corticosteroid side effects, and we were unable to conduct any meta‐analysis for this outcome. Oral steroids compared to no treatment Oral steroids may result in little or no difference in the persistence of OME after three to nine months (74.5% children receiving steroids versus 73% of those receiving placebo; RR 1.02, 95% CI 0.89 to 1.17; 2 studies, 258 participants; low‐certainty evidence). The evidence on adverse effects was very uncertain. We did not identify any evidence on hearing or disease‐related quality of life. Topical (intranasal) steroids compared to placebo We did not identify data on the proportion of children who returned to normal hearing. However, the mean change in hearing threshold after two months was ‐0.3 dB lower (95% CI ‐6.05 to 5.45; 1 study, 78 participants; very low‐certainty evidence). The evidence suggests that nasal steroids make little or no difference to disease‐specific quality of life after nine months (OM8‐30 score, MD 0.05 higher, 95% CI ‐0.36 to 0.46; 1 study, 82 participants; low‐certainty evidence). The evidence is very uncertain regarding the effect of nasal steroids on persistence of OME at up to one year. Two studies reported this: one showed a potential benefit for nasal steroids, the other showed a benefit with placebo (2 studies, 206 participants). The evidence was also very uncertain regarding the risk of corticosteroid‐related side effects, as we were unable to provide a pooled effect estimate. Topical (intranasal) steroids compared to no treatment We did not identify data on the proportion of children who returned to normal hearing. However, the mean difference in final hearing threshold after four weeks was 1.95 dB lower (95% CI ‐3.85 to ‐0.05; 1 study, 168 participants; low‐certainty evidence). Nasal steroids may reduce the persistence of OME after eight weeks, but the evidence was very uncertain (58.5% of children receiving steroids, compared to 81.3% of children without treatment, RR 0.72, 95% CI 0.57 to 0.91; 2 studies, 134 participants). We did not identify any evidence on disease‐related quality of life or adverse effects. Authors' conclusions Overall, oral steroids may have little effect in the treatment of OME, with little improvement in the number of children with normal hearing and no effect on quality of life. There may be a reduction in the proportion of children with persistent disease after 12 months. However, this benefit may be small and must be weighed against the potential for adverse effects associated with oral steroid use. The evidence for nasal steroids was all low‐ or very low‐certainty. It is therefore less clear if nasal steroids have any impact on hearing, quality of life or persistence of OME. Evidence on adverse effects was very limited. OME is likely to resolve spontaneously for most children. The potential benefit of treatment may therefore be small and should be balanced with the risk of adverse effects. Future studies should aim to determine which children are most likely to benefit from treatment, rather than offering interventions to all children.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
17秒前
dada完成签到,获得积分10
37秒前
ainiyiwannian完成签到,获得积分10
50秒前
坚强夜梦完成签到,获得积分10
55秒前
HT完成签到 ,获得积分10
1分钟前
风趣的紫霜完成签到 ,获得积分10
1分钟前
田様的应助被Mole采纳,获得10
1分钟前
1分钟前
Mole发布了新的文献求助10
1分钟前
2分钟前
2分钟前
2分钟前
Lucas的应助被Mole采纳,获得10
2分钟前
xiaojiu完成签到,获得积分10
2分钟前
2分钟前
2分钟前
spinon发布了新的文献求助20
2分钟前
Mole发布了新的文献求助10
2分钟前
Mole完成签到,获得积分10
3分钟前
3分钟前
Dryang完成签到 ,获得积分10
3分钟前
窗窗窗雨完成签到,获得积分10
3分钟前
amiee发布了新的文献求助10
3分钟前
蝎子莱莱xth完成签到,获得积分0
3分钟前
超帅的幻枫完成签到,获得积分10
3分钟前
氢锂钠钾铷铯钫完成签到,获得积分10
3分钟前
东风完成签到,获得积分10
3分钟前
fjmelite完成签到 ,获得积分10
3分钟前
完美世界的应助被choup53采纳,获得10
3分钟前
Square完成签到,获得积分10
3分钟前
如意的鼠标完成签到 ,获得积分10
3分钟前
lzq671完成签到 ,获得积分10
4分钟前
在水一方的应助被科研通管家采纳,获得10
4分钟前
ding的应助被科研通管家采纳,获得10
4分钟前
4分钟前
faust0052完成签到 ,获得积分10
4分钟前
浚稚完成签到 ,获得积分0
5分钟前
wood完成签到,获得积分10
5分钟前
aiyouwei完成签到,获得积分10
5分钟前
乐观的素阴完成签到 ,获得积分10
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190226
求助须知:如何正确求助?哪些是违规求助? 9577371
关于积分的说明 21852394
捐赠科研通 7788780
什么是DOI,文献DOI怎么找? 3436315
关于科研通互助平台的介绍 2560109
邀请新用户注册赠送积分活动 2482945